Grace Therapeutics, Inc. (GRCE) Operating margin 2022–2023
Grace Therapeutics, Inc. (GRCE) operating margin by fiscal year — reported operating income divided by reported revenue.
-52.2%FY2023 · since FY2022: -7953.6% → -52.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -52.2% | +7901.4 pp |
| FY2022 | -7953.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice